|
1
|
Lu X, Li X, Zhao Y, Zheng Z, Guan S and
Chan P: Contemporary epidemiology of gout and hyperuricemia in
community elderly in Beijing. Int J Rheum Dis. 17:400–407. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Stamp LK and Chapman PT: Gout and its
comorbidities: Implications for therapy. Rheumatology (Oxford).
52:34–44. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pan BQ, Pan JK, Liu J and Yang JY:
Analysis on medication rule in herbal prescriptions for gout based
on apriori and clustering algorithm. China J Trad Chin Med
Pharmacy. 29:2040–2043. 2014.(In Chinese).
|
|
4
|
Zhu L, Dong Y, Na S, Han R, Wei C and Chen
G: Saponins extracted from Dioscorea collettii rhizomes
regulate the expression of urate transporters in chronic
hyperuricemia rats. Biomed Pharmacother. 93:88–94. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kingsbury SR, Conaghan PG and McDermott
MF: The role of the NLRP3 inflammasome in gout. J Inflamm Res.
4:39–49. 2011.PubMed/NCBI
|
|
6
|
Martinon F and Tschopp J: Inflammatory
caspases and inflammasomes: Master switches of inflammation. Cell
Death Differ. 14:10–22. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Huang HG, Sun YF, Hu M, Yuan GS, Wang Q
and Liu YX: Characteristics of monosodium urate monohydrate
crystal-induced acute arthritis in rats that mimicked human gouty
arthritis. Bulletin of the Academy of Military (Medicinal
Sciences). 29:538–542. 2005.
|
|
8
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kawakami A, Tani M, Chiba T, Yui K,
Shinozaki S, Nakajima K, Tanaka A, Shimokado K and Yoshida M:
Pitavastatin inhibits remnant lipoprotein-induced macrophage foam
cell formation through ApoB48 receptor-dependent mechanism.
Arterioscler Thromb Vasc Biol. 25:424–429. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Park EK, Jung HS, Yang HI, Yoo MC, Kim C
and Kim KS: Optimized THP-1 differentiation is required for the
detection of responses to weak stimuli. Inflamm Res. 56:45–50.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xian H, Wang P, Jing H, Chen GQ, Cheng DF,
Ji F, Song S and Zhang L: Comparative study of components and
anti-oxidative effects between sulfated polysaccharide and its iron
complex. Int J Biol Macromol. 118:1303–1309. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhao Y, Zheng J, Yu Y and Wang L: Panax
notoginseng saponins regulate macrophage polarization under
hyperglycemic condition via NF-κB signaling pathway. Biomed Res
Int. 2018:92393542018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Schwende H, Fitzke E, Ambs P and Dieter P:
Differences in the state of differentiation of THP-1 cells induced
by phorbol ester and 1,25-dihydroxyvitamin D3. J Leukoc Biol.
59:555–561. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Martinon F, Petrilli V, Mayor A, Tardivel
A and Tschopp J: Gout-associated uric acid crystals activate the
NALP3 inflammasome. Nature. 440:237–241. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chhana A, Pool B, Callon KE, Tay ML,
Musson D, Naot D, McCarthy G, McGlashan S, Cornish J and Dalbeth N:
Monosodium urate crystals reduce osteocyte viability and indirectly
promote a shift in osteocyte function towards a proinflammatory and
proresorptive state. Arthritis Res Ther. 20:2082018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sil P, Wicklum H, Surell C and Rada B:
Macrophage-derived IL-1 beta enhances monosodium urate
crystal-triggered NET formation. Inflamm Res. 66:227–237. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Eisenbarth SC, Colegio OR, O'Connor W,
Sutterwala FS and Flavell RA: Crucial role for the Nalp3
inflammasome in the immunostimulatory properties of aluminium
adjuvants. Nature. 453:1122–1126. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
van de Veerdonk FL, Netea MG, Dinarello CA
and Joosten LA: Inflammasome activation and IL-1β and IL-18
processing during infection. Trends Immunol. 32:110–116. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mankan AK, Dau T, Jenne D and Hornung V:
The NLRP3/ASC/Caspase-1 axis regulates IL-1β processing in
neutrophils. Eur J Immunol. 42:710–715. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wen H, Gris D, Lei Y, Jha S, Zhang L,
Huang MT, Brickey WJ and Ting JP: Fatty acid-induced NLRP3-ASC
inflammasome activation interferes with insulin signaling. Nat
Immunol. 12:408–415. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
He X, Mekasha S, Mavrogiorgos N,
Fitzgerald KA, Lien E and Ingalls RR: Inflammation and fibrosis
during Chlamydia pneumoniae infection is regulated by IL-1 and the
NLRP3/ASC inflammasome. J Immunol. 184:5743–5754. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zheng SC, Zhu XX, Xue Y, Zhang LH, Zou HJ,
Qiu JH and Liu Q: Role of the NLRP3 inflammasome in the transient
release of IL-1β induced by monosodium urate crystals in human
fibroblast-like synoviocytes. J Inflamm (Lond). 12:302015.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gicquel T, Robert S, Loyer P, Victoni T,
Bodin A, Ribault C, Gleonnec F, Couillin I, Boichot E and Lagente
V: IL-1β production is dependent on the activation of purinergic
receptors and NLRP3 pathway in human macrophages. FASEB J.
29:4162–4173. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ma Q, Chen S, Hu Q, Feng H, Zhang JH and
Tang J: NLRP3 inflammasome contributes to inflammation after
intracerebral hemorrhage. Ann Neurol. 75:209–219. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kawai T and Akira S: The roles of TLRs,
RLRs and NLRs in pathogen recognition. Int Immunol. 21:317–337.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Landis RC and Haskard DO: Pathogenesis of
crystal-induced inflammation. Curr Rheumatol Rep. 3:36–41. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lamprecht P, Till A and Kabelitz D: New
aspects of the pathogenesis of gout. Danger signals,
autoinflammation and beyond. Z Rheumatol. 67:151–156. 2008.(In
German). View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Janssen CA, Oude Voshaar MAH, Vonkeman HE,
Jansen TLTA, Janssen M, Kok MR, Radovits B, van Durme C, Baan H and
van de Laar MAFJ: Anakinra for the treatment of acute gout flares:
A randomized, double-blind, placebo-controlled, active-comparator,
non-inferiority trial. Rheumatology (Oxford). 2019.(Epub ahead of
print). View Article : Google Scholar :
|
|
29
|
Sundy JS, Schumacher HR, Kivitz A,
Weinstein SP, Wu R, King-Davis S and Evans RR: Rilonacept for gout
flare prevention in patients receiving uric acid-lowering therapy:
results of RESURGE, a phase III, international safety study. J
Rheumatol. 41:1703–1711. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Schlesinger N, Alten RE, Bardin T, et al:
Canakinumab for acute gouty arthritis in patients with limited
treatment options: Results from two randomised, multicentre,
active-controlled, double-blind trials and their initial
extensions. Ann Rheum Dis. 71:1839–1848. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Richette P, Doherty M, Pascual E, Barskova
V, Becce F, Castañeda-Sanabria J, Coyfish M, Guillo S, Jansen TL,
Janssens H, et al: 2016 updated EULAR evidence-based
recommendations for the management of gout. Ann Rheum Dis.
76:29–42. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chen GL, Wei W and Xu SY: Effect and
mechanism of total saponin of dioscorea on animal experimental
hyperuricemia. Am J Chin Med. 34:77–85. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Martin WJ, Walton M and Harper J: Resident
macrophages initiating and driving inflammation in a monosodium
urate monohydrate crystal-induced murine peritoneal model of acute
gout. Arthritis Rheum. 60:281–289. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Pope RM and Tschopp J: The role of
interleukin-1 and the inflammasome in gout: Implications for
therapy. Arthritis Rheum. 56:3183–3188. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Scott P, Ma H, Viriyakosol S, Terkeltaub R
and Liu-Bryan R: Engagement of CD14 mediates the inflammatory
potential of monosodium urate crystals. J Immunol. 177:6370–6378.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Martin WJ, Shaw O, Liu X, Steiger S and
Harper JL: Monosodium urate monohydrate crystal-recruited
noninflammatory monocytes differentiate into M1-like
proinflammatory macrophages in a peritoneal murine model of gout.
Arthritis Rheum. 63:1322–1332. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Schroder K, Zhou R and Tschopp J: The
NLRP3 inflammasome: A sensor for metabolic danger? Science.
327:296–300. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Choe JY, Jung HY, Park KY and Kim SK:
Enhanced p62 expression through impaired proteasomal degradation is
involved in caspase-1 activation in monosodium urate
crystal-induced interleukin-1β expression. Rheumatology (Oxford).
53:1043–1053. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Terkeltaub R, Zachariae C, Santoro D,
Martin J, Peveri P and Matsushima K: Monocyte-derived neutrophil
chemotactic factor/interleukin-8 is a potential mediator of
crystal-induced inflammation. Arthritis Rheum. 34:894–903. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Liu Q, Zhang D, Hu D, Zhou X and Zhou Y:
The role of mitochondria in NLRP3 inflammasome activation. Mol
Immunol. 103:115–124. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Punzi L, Scanu A, Ramonda R and Oliviero
F: Gout as autoinflammatory disease: New mechanisms for more
appropriated treatment targets. Autoimmun Rev. 12:66–71. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zheng SC, Zhu XX, Xue Y, Zhang LH, Zou HJ,
Qiu JH and Liu Q: Role of the NLRP3 inflammasome in the transient
release of IL-1 β induced by monosodium urate crystals in human
fibroblast-like synoviocytes. J Inflamm (Lond). 12:302015.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Lu W, Sha N and Guang-liang C: Effect of
total saponin of Dioscorea on NALP3 inflammasome signaling pathway
with acute gouty in rats. Chinese Pharmacological Bulletin.
33:354–360. 2017.
|
|
44
|
Blomgran R, Patcha Brodin V, Verma D,
Bergström I, Söderkvist P, Sjöwall C, Eriksson P, Lerm M, Stendahl
O and Särndahl E: Common genetic variations in the NALP3
inflammasome are associated with delayed apoptosis of human
neutrophils. PLoS One. 7:e313262012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Kool M, Petrilli V, De Smedt T, Rolaz A,
Hammad H, van Nimwegen M, Bergen IM, Castillo R, Lambrecht BN and
Tschopp J: Cutting edge: Alum adjuvant stimulates inflammatory
dendritic cells through activation of the NALP3 inflammasome. J
Immunol. 181:3755–3759. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Hornung V, Bauernfeind F, Halle A, Samstad
EO, Kono H, Rock KL, Fitzgerald KA and Latz E: Silica crystals and
aluminum salts activate the NALP3 inflammasome through phagosomal
destabilization. Nat Immunol. 9:847–856. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Dostert C, Petrilli V, Van Bruggen R,
Steele C, Mossman BT and Tschopp J: Innate immune activation
through Nalp3 inflammasome sensing of asbestos and silica. Science.
320:674–677. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Cassel SL, Eisenbarth SC, Iyer SS, Sadler
JJ, Colegio OR, Tephly LA, Carter AB, Rothman PB, Flavell RA and
Sutterwala FS: The Nalp3 inflammasome is essential for the
development of silicosis. Proc Natl Acad Sci USA. 105:9035–9040.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Halle A, Hornung V, Petzold GC, Stewart
CR, Monks BG, Reinheckel T, Fitzgerald KA, Latz E, Moore KJ and
Golenbock DT: The NALP3 inflammasome is involved in the innate
immune response to amyloid-beta. Nat Immunol. 9:857–865. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Ozaki E, Campbell M and Doyle SL:
Targeting the NLRP3 inflammasome in chronic inflammatory diseases:
Current perspectives. J Inflamm Res. 8:15–27. 2015.PubMed/NCBI
|
|
51
|
Menu P and Vince JE: The NLRP3
inflammasome in health and disease: The good, the bad and the ugly.
Clin Exp Immunol. 166:1–15. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Mason DR, Beck PL and Muruve DA:
Nucleotide-binding oligomerization domain-like receptors and
inflammasomes in the pathogenesis of non-microbial inflammation and
diseases. J Innate Immun. 4:16–30. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Ogura Y, Sutterwala FS and Flavell RA: The
inflammasome: First line of the immune response to cell stress.
Cell. 126:659–662. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Zhou Q, Yu DH, Zhang N and Liu SM:
Anti-inflammatory effect of total saponin fraction from
Dioscorea nipponica Makino on gouty arthritis and its
influence on NALP3 inflammasome. Chin J Integr Med. 25:663–670.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Yang D, Elner SG, Bian ZM, Till GO, Petty
HR and Elner VM: Pro-inflammatory cytokines increase reactive
oxygen species through mitochondria and NADPH oxidase in cultured
RPE cells. Exp Eye Res. 85:462–472. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Bordt EA and Polster BM: NADPH oxidase-
and mitochondria-derived reactive oxygen species in proinflammatory
microglial activation: A bipartisan affair? Free Radic Biol Med.
76:34–46. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Won JH, Park S, Hong S, Son S and Yu JW:
Rotenone-induced impairment of mitochondrial electron transport
chain confers a selective priming signal for NLRP3 inflammasome
activation. J Biol Chem. 290:27425–27437. 2015. View Article : Google Scholar : PubMed/NCBI
|
